Figure 5
From: Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer
In silico analysis of FGFR4 expression in prostate cancer patients (A). Effect of FGFR4 expression level on prostate cancer participant’s overall survival (OS) time (B).
